Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs (Find 4 items)

Blood System Drugs

Etamsylate

(2624-44-4)
Hemostatic;prostaglandin synthesis inhibitor he product can increase the number, aggregation and adhesion of platelets, and promote the release of coagulation active substances from platelets. It can also accelerate the contraction of blood clots, shorten the clotting time, enhance the resistance of capillaries, and reduce capillary permeability. Used to prevent and treat bleeding before surgery. It is also used for bleeding caused by platelet insufficiency or other causes, such as gastrointest

Product List

Request for quotation , get quotes from more suppliers.

Ethyl α-oxobenzenebutanoate

(64920-29-2)
Lisinopril intermediate. Used as organic synthesis intermediate and pharmaceutical intermediate

Product List

Request for quotation , get quotes from more suppliers.

Hematological diseases refer to diseases that are primary (such as leukemia) or mainly involve blood (such as iron deficiency anemia) and hematopoietic organs. Classification: red blood cell diseases, such as various types of anemia and polycythemia, etc .; granulocyte diseases, such as leukopenia and agranulocytosis, neutrophil lobular insufficiency, inert leukocyte syndrome, and leukemia-like reactions. Blood system drugs mainly include: anti-anemic drugs, leukocyte-raising drugs, antiplatelet drugs, procoagulant drugs, anticoagulant drugs and thrombolytic drugs, blood volume expansion agents, leukocyte-raising drugs, antiplatelet drugs and other drugs. The "Blood System Drugs" on ECHEMI classification list mainly supplies APIs for these drugs.
Complaint
Email:
Message:
Send Message